Exposure to tuberculous infection
Sics Editore
āļ.āļ. 2014 · SICS Editore
eBook
47
āļŦāļāđāļē
family_home
āļĄāļĩāļŠāļīāļāļāļīāđ
info
reportāļāļ°āđāļāļāđāļĨāļ°āļĢāļĩāļ§āļīāļ§āđāļĄāđāđāļāđāļĢāļąāļāļāļēāļĢāļāļĢāļ§āļāļŠāļāļāļĒāļ·āļāļĒāļąāļ Â āļāļđāļāđāļāļĄāļđāļĨāđāļāļīāđāļĄāđāļāļīāļĄ
āđāļāļĩāđāļĒāļ§āļāļąāļ eBook āđāļĨāđāļĄāļāļĩāđ
In practice, only pulmonary tuberculosis is infectious.
The infection is spread by a coughing patient who sheds such high numbers of bacilli in the sputum that they can be demonstrated by staining of a sputum smear. This requires 10Â 000â100Â 000 bacilli per 1 ml of sputum.
On the other hand, a culture of tubercle bacilli is positive at concentrations as low as 10â100 bacilli per ml. Such low concentrations carry only minimal risk of spreading the infection.
The standard treatment regimen consists of rifampicin (RMP) and isoniazid (INH) for 6 months combined with pyrazinamide (PZA) during the first 2 months. Sometimes ethambutol is used as the third drug.
Regular intake of the drugs is essential for treatment success.
The infection is spread by a coughing patient who sheds such high numbers of bacilli in the sputum that they can be demonstrated by staining of a sputum smear. This requires 10Â 000â100Â 000 bacilli per 1 ml of sputum.
On the other hand, a culture of tubercle bacilli is positive at concentrations as low as 10â100 bacilli per ml. Such low concentrations carry only minimal risk of spreading the infection.
The standard treatment regimen consists of rifampicin (RMP) and isoniazid (INH) for 6 months combined with pyrazinamide (PZA) during the first 2 months. Sometimes ethambutol is used as the third drug.
Regular intake of the drugs is essential for treatment success.
āđāļŦāđāļāļ°āđāļāļ eBook āļāļĩāđ
āđāļŠāļāļāļāļ§āļēāļĄāđāļŦāđāļāļāļāļāļāļļāļāđāļŦāđāđāļĢāļēāļĢāļąāļāļĢāļđāđ
āļāđāļāļĄāļđāļĨāđāļāļāļēāļĢāļāđāļēāļ
āļŠāļĄāļēāļĢāđāļāđāļāļāđāļĨāļ°āđāļāđāļāđāļĨāđāļ
āļāļīāļāļāļąāđāļāđāļāļ Google Play Books āļŠāļģāļŦāļĢāļąāļ Android āđāļĨāļ° iPad/iPhone āđāļāļāļāļ°āļāļīāļāļāđāđāļāļĒāļāļąāļāđāļāļĄāļąāļāļīāļāļąāļāļāļąāļāļāļĩāļāļāļāļāļļāļ āđāļĨāļ°āļāđāļ§āļĒāđāļŦāđāļāļļāļāļāđāļēāļāđāļāļāļāļāļāđāļĨāļāđāļŦāļĢāļ·āļāļāļāļāđāļĨāļāđāđāļāđāļāļļāļāļāļĩāđ
āđāļĨāđāļāļāđāļāļāđāļĨāļ°āļāļāļĄāļāļīāļ§āđāļāļāļĢāđ
āļāļļāļāļāļąāļāļŦāļāļąāļāļŠāļ·āļāđāļŠāļĩāļĒāļāļāļĩāđāļāļ·āđāļāļāļēāļ Google Play āđāļāļĒāđāļāđāđāļ§āđāļāđāļāļĢāļēāļ§āđāđāļāļāļĢāđāđāļāļāļāļĄāļāļīāļ§āđāļāļāļĢāđāđāļāđ
eReader āđāļĨāļ°āļāļļāļāļāļĢāļāđāļāļ·āđāļāđ
āļŦāļēāļāļāđāļāļāļāļēāļĢāļāđāļēāļāļāļāļāļļāļāļāļĢāļāđ e-ink āđāļāđāļ Kobo eReader āļāļļāļāļāļ°āļāđāļāļāļāļēāļ§āļāđāđāļŦāļĨāļāđāļĨāļ°āđāļāļāđāļāļĨāđāđāļāļĒāļąāļāļāļļāļāļāļĢāļāđāļāļāļāļāļļāļ āđāļāļĢāļāļāļģāļāļēāļĄāļ§āļīāļāļĩāļāļēāļĢāļāļĒāđāļēāļāļĨāļ°āđāļāļĩāļĒāļāđāļāļĻāļđāļāļĒāđāļāđāļ§āļĒāđāļŦāļĨāļ·āļāđāļāļ·āđāļāđāļāļāđāļāļĨāđāđāļāļĒāļąāļ eReader āļāļĩāđāļĢāļāļāļĢāļąāļ
